➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Baxter
Harvard Business School
Merck
Dow
McKinsey

Last Updated: April 10, 2021

DrugPatentWatch Database Preview

Litigation Details for HORIZON MEDICINES LLC v. DR. REDDY'S LABORATORIES INC. (D.N.J. 2015)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in HORIZON MEDICINES LLC v. DR. REDDY'S LABORATORIES INC.
The small molecule drugs covered by the patents cited in this case are   Start Trial and   Start Trial .

Details for HORIZON MEDICINES LLC v. DR. REDDY'S LABORATORIES INC. (D.N.J. 2015)

Date Filed Document No. Description Snippet Link To Document
2019-11-08 231 motion, when filed, concerned six patents: U.S. Patent Nos. 8,852,636, 8,858,996, 8,865,190, 9,161,920…U.S. Patent No. 8,858,996 (the “’996 patent”) and claims 1-5, 7-9, 11-14 of U.S. Patent No. …’s claims for those patents from the six patents that do not involve the patent claims included in Plaintiffs…. 9,161,920 (the “’920 patent”) (collectively, “the Asserted Patents”) to be asserted in this…Asserted Patents.” This motion, then, concerns the identified claims in the Asserted Patents only. External link to document
2019-12-18 252 arose. The two patents presently at issue descend from U.S. Patent No. 6,926,907: U.S. Patent Nos. 8,858,996…litigation involved U.S. Patent Nos. 6,926,907 and 8,557,285.2 Those patents 1 DRL has filed ANDA…prosecution history of a parent patent, the ‘907 patent. The ‘920 and ‘996 patents descended from the application…litigation regarding patents related to the drug Vimovo®. Plaintiff Nuvo owns the patents, Plaintiff Horizon…8,858,996 (the “’996 patent”) and 9,161,920 (the “’920 patent”). APPLICABLE External link to document
2021-01-05 334 Opinion - USCA stomach acid secretion. U.S. Patent Nos. 9,220,698 (the ’698 patent) and 9,393,208 (the ’208…judgment that the claims of U.S. Patent Nos. 9,220,698 and 9,393,208 are invalid for indefi- …the ’698 patent is rep- resentative of the asserted claims of both the ’698 patent …asserted claims of the ’698 patent and the ’208 patent invalid due to indefi- … the claims of the ’698 patent and the ’208 patent are invalid for indef- External link to document
2021-02-16 340 Order on Motion for Summary Judgment . The two patents presently at issue descend from U.S. Patent No. 6,926,907: U.S. Patent Nos. 8,858,996…litigation involved U.S. Patent Nos. 6,926,907 and 8,557,285.1 Those patents have been found to be invalid…litigation regarding patents related to the drug Vimovo®. Plaintiff Nuvo owns the patents, Plaintiff Horizon…8,858,996 (the “’996 patent”) and 9,161,920 (the “’920 patent”). DRL moves for summary judgment…Independent claim 11 of the ‘920 patent and claim 12 of the ‘996 patent both expressly require that the External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Merck
Harvard Business School
McKesson
Medtronic
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.